A Clinical Trial to Evaluate the Effects of a Fibre Supplement on Microbiome and Gut Health

Summary

This study will evaluate the effects of the Artah Essential Fibre+ supplement on the microbiome and gut health over an 8-week period. The study is a single-arm, unblinded virtual trial enrolling 50 participants who will consume the test product daily and complete questionnaires at Baseline, Week 2, Week 4, Week 6, and Week 8.

A subgroup of 30 participants will provide stool samples for microbiome testing at Baseline and Week 8. All participants will provide body composition measurements using a smart scale at Baseline, Week 4, and Week 8. Secondary outcomes include participants' self-reported perceptions of the product's effects on gut health, metabolism, food cravings, appetite, and general well-being.

Conditions

• Gut Health
• Microbiome
• Bloating
• Indigestion
• Constipation
• Diarrhea
• Food Cravings
• Abdominal Discomfort
• Bowel Movement Irregularity

Interventions

DIETARY_SUPPLEMENT

Essential Fibre+

All 50 participants receive the Artah Essential Fibre+ supplement once daily in the morning before the first meal of the day, mixed with 500ml of water. Dosing is graduated: one scoop on Days 1-3, two scoops on Days 4-6, and three scoops from Day 7 onwards for the remainder of the 8-week study period.

Sponsors & Collaborators

• Citruslabs

  collaborator INDUSTRY

• Artah Nutrition Limited

  lead INDUSTRY

Study Design

Allocation

NA

Purpose

TREATMENT

Masking

NONE

Model

SINGLE_GROUP

Eligibility

Min Age

21 Years

Max Age

65 Years

Sex

ALL

Healthy Volunteers

No

Timeline & Regulatory

Start

2026-06-01

Primary Completion

2026-09-30

Completion

2026-09-30

Countries

• United States

Study Locations